QBB95

QBB95 is a chemical compound with the molecular formula C18H24N2O2. It is a synthetic derivative of the benzodiazepine class of drugs, which are known for their anxiolytic, sedative, hypnotic, muscle relaxant, and anticonvulsant properties. QBB95 was developed as a research tool to study the effects of benzodiazepines on the central nervous system. It is not approved for human use and is primarily used in scientific and pharmaceutical research settings. The compound is known to bind to the GABA-A receptor, enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits neuron activity. This action results in the sedative, anxiolytic, and muscle relaxant effects observed with QBB95. Research involving QBB95 has contributed to our understanding of the mechanisms of action of benzodiazepines and their potential therapeutic applications. However, due to the risks and side effects associated with benzodiazepines, such as dependence, tolerance, and respiratory depression, QBB95 is not recommended for clinical use. Its primary use remains in the realm of scientific research to further our knowledge of the central nervous system and the effects of psychoactive substances.